文献速递泌尿生殖腹部PETMRCT

回顾性融合64CuCl2 PET/MRI在前列腺癌生化复发中的诊断价值:与融合18F-胆碱PET/MRI、64CuCl2 PET/CT、18F-胆碱PET/CT及mpMRI的比较

Diagnostic value of retrospectively fused 64CuCl2 PET/MRI in biochemical relapse of prostate cancer: comparison with fused 18F-Choline PET/MRI, 64CuCl2 PET/CT, 18F-Choline PET/CT, and mpMRI.
PubMed 文献 · Abdom Radiol (NY) · 2020-01-01

本研究回顾性评估50例根治性前列腺切除或放疗后生化复发的前列腺癌患者,比较融合64CuCl2 PET/MRI与融合18F-胆碱PET/MRI的检出率,并比较融合PET/MRI与各单独影像模态的检出率。患者基于分析中融合64CuCl2 PET/MRI总检出率88%最高,融合18F-胆碱PET/MRI为68%;病灶基于分析中分别为95%和66%。结论认为回顾性融合PET/MRI能克服单独解读各影像模态的局限性,融合64CuCl2 PET/MRI在前列腺癌局部复发检测中诊断性能最高。

要点

  • 患者基于分析中融合64CuCl2 PET/MRI检出率88%,高于融合18F-胆碱PET/MRI的68%。
  • 病灶基于分析中融合64CuCl2 PET/MRI检出率95%,高于融合18F-胆碱PET/MRI的66%。
  • 融合64CuCl2 PET/MRI在检测前列腺癌局部复发方面诊断性能最高。

诊断标准与关键数值

  • 患者基于分析中,融合64CuCl2 PET/MRI、融合18F-胆碱PET/MRI、64CuCl2 PET/CT、18F-胆碱PET/CT和mpMRI的总检出率分别为88%、68%、82%、56%和74%。
  • 病灶基于分析中,融合64CuCl2 PET/MRI、融合18F-胆碱PET/MRI、64CuCl2 PET/CT、18F-胆碱PET/CT和mpMRI的总检出率分别为95%、66%、87%、58%和71%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To assess the diagnostic value of retrospectively fused PET/MRI by comparing the detection rates (DRs) of fused 64CuCl2 PET/MRI vs. fused 18F-Choline PET/MRI in patients with suspected prostatic cancer (PCa) recurrence. The secondary objective was to compare the DRs of fused PET/MRI vs. those of the separate imaging modalities.

METHODS: We retrospectively evaluated 50 PCa patients with biochemical relapse after radical prostatectomy (RP) or radiotherapy (RT). All patients underwent 64CuCl2 PET/CT, 18F-Choline PET/CT, and multiparametric magnetic resonance imaging (mpMRI) within 15 days. Fused 64CuCl2-PET/MRI and fused 18F-Choline PET/MRI images were obtained by retrospective co-registration of MRI and PET images. Experienced readers interpreted the images, and the DRs of each imaging modality were assessed.

RESULTS: In the patient-based analysis, overall DRs of fused 64CuCl2 PET/MRI, fused 18F-Choline PET/MRI, 64CuCl2 PET/CT, 18F-Choline PET/CT, and mpMRI were 88%, 68%, 82%, 56%, and 74%, respectively. In the lesion-based analysis, overall DRs of fused 64CuCl2 PET/MRI, fused 18F-Choline PET/MRI, 64CuCl2 PET/CT, 18 F-Choline PET/CT, and mpMRI were 95%, 66%, 87%, 58%, and 71%, respectively.

CONCLUSIONS: Retrospectively fused PET/MRI is able to overcome the limitations of the separate interpretation of the individual imaging modalities. Fused 64CuCl2 PET/MRI provided the highest diagnostic performance in the detection of PCa local relapse.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Paparo F, Peirano A, Matos J, et al. Diagnostic value of retrospectively fused 64CuCl2 PET/MRI in biochemical relapse of prostate cancer: comparison with fused 18F-Choline PET/MRI, 64CuCl2 PET/CT, 18F-Choline PET/CT, and mpMRI. Abdom Radiol (NY). 2020. PMID: 32451674. doi:10.1007/s00261-020-02591-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。